最高學歷
國防醫學院 醫學科學研究所 博士
經歷
2023. 08-present 國防部軍醫局少校視察
2021. 05-2023.07 國防部軍醫局少校科員
2019. 12-2021.04 國防部醫務組少校藥劑官
2014. 03-2019.11 三軍總醫院採購官、衛補官、裝審會幹事
研究領域
腦癌致病基因之篩選與分子機制、基因依賴性與藥物合併療效評估、生物資訊學探討基因體與疾病之關聯性
著作
1.Chen SH, Chiu SJ, Hu TM. Superoxide dismutase as a novel macromolecular nitric oxide carrier: preparation and characterization. Int J Mol Sci. 2012 Oct 29;13(11):13985-4001
2.Chen SH, Lin HH, Li YF, Tsai WC, Hueng DY. Clinical Significance and Systematic Expression Analysis of the Thyroid Receptor Interacting Protein 13 (TRIP13) as Human Gliomas Biomarker. Cancers (Basel). 2021 May 12;13(10):2338.
3.Lin HH, Tsai WC, Tsai CK, Chen SH, Huang LC, Hueng DY, Hung KC. Overexpression of Cell-Surface Marker SLC16A1 Shortened Survival in Human High-Grade Gliomas. J Mol Neurosci. 2021 Aug;71(8):1614-1621.
4.Kao Y, Tsai WC, Chen SH, Hsu SY, Huang LC, Chang CJ, Huang SM, Hueng DY. Shugosin 2 is a biomarker for pathological grading and survival prediction in patients with gliomas. Sci Rep. 2021 Sep 17;11(1):18541.
5.Chou YL, Hsu KF, Chen SH, Lin SY, Yeh MK, Lin CK, Tsai YM. Distinct Biodistribution of Natural Killer Cell-Derived Exosomes in an Orthotopic A549 Lung Cancer Mouse Model: Implications for Potent Targeted Drug Delivery. Life (Basel). 2026 Apr 13;16(4):654.
主持計畫
1.To investigate the cytotoxicity and the molecular mechanism of NK exosomes combined with Temozolomide on temozolomideresistant glioblastoma (115年國防研究計畫，執行中)
2.Brain tumor and neuroblastoma genome-wide association studies dissect shared genetic backgrounds underlying carcinogenesis (115年國軍桃園民診計畫，執行中)
3.Integrating Transcriptomic and Dependency Profiling to Explore Vulnerabilities as Lethal Targets in PTEN-mutant Glioblastoma (116年國軍桃園民診計畫，已送審)
4.IIntegrating Transcriptomic and Dependency Profiling to Uncover Metabolic Vulnerabilities as Lethal Targets in Ewing Sarcoma (116年三總民診計畫，已送審)